Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Optogenetic control of chemokine receptor signal and T-cell migration.

Xu Y, Hyun YM, Lim K, Lee H, Cummings RJ, Gerber SA, Bae S, Cho TY, Lord EM, Kim M.

Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6371-6. doi: 10.1073/pnas.1319296111.

2.

Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control.

Vianello F, Papeta N, Chen T, Kraft P, White N, Hart WK, Kircher MF, Swart E, Rhee S, Palù G, Irimia D, Toner M, Weissleder R, Poznansky MC.

J Immunol. 2006 Mar 1;176(5):2902-14. Erratum in: J Immunol. 2006 May 1;176(9):5683.

3.

Spatiotemporal control of fibroblast growth factor receptor signals by blue light.

Kim N, Kim JM, Lee M, Kim CY, Chang KY, Heo WD.

Chem Biol. 2014 Jul 17;21(7):903-12. doi: 10.1016/j.chembiol.2014.05.013.

5.

SDF-1/CXCL12 induces directional cell migration and spontaneous metastasis via a CXCR4/Gαi/mTORC1 axis.

Dillenburg-Pilla P, Patel V, Mikelis CM, Zárate-Bladés CR, Doçi CL, Amornphimoltham P, Wang Z, Martin D, Leelahavanichkul K, Dorsam RT, Masedunskas A, Weigert R, Molinolo AA, Gutkind JS.

FASEB J. 2015 Mar;29(3):1056-68. doi: 10.1096/fj.14-260083.

6.

Preferential involvement of CX chemokine receptor 4 and CX chemokine ligand 12 in T-cell migration toward melanoma cells.

Zhang T, Somasundaram R, Berking C, Caputo L, Van Belle P, Elder D, Czerniecki B, Hotz S, Schuchter L, Spitz FR, Berencsi K, Rani P, Marincola F, Qiu R, Herlyn D.

Cancer Biol Ther. 2006 Oct;5(10):1304-12.

PMID:
16929176
7.

Cutting edge: T cell migration regulated by CXCR4 chemokine receptor signaling to ZAP-70 tyrosine kinase.

Ottoson NC, Pribila JT, Chan AS, Shimizu Y.

J Immunol. 2001 Aug 15;167(4):1857-61.

8.

The murine chemokine receptor CXCR4 is tightly regulated during T cell development and activation.

Schabath R, Müller G, Schubel A, Kremmer E, Lipp M, Förster R.

J Leukoc Biol. 1999 Dec;66(6):996-1004.

PMID:
10614783
9.

Leukocyte-endothelium interaction promotes SDF-1-dependent polarization of CXCR4.

van Buul JD, Voermans C, van Gelderen J, Anthony EC, van der Schoot CE, Hordijk PL.

J Biol Chem. 2003 Aug 8;278(32):30302-10.

10.

Involvement of phosphatidylinositol 3-kinase in stromal cell-derived factor-1 alpha-induced lymphocyte polarization and chemotaxis.

Vicente-Manzanares M, Rey M, Jones DR, Sancho D, Mellado M, Rodriguez-Frade JM, del Pozo MA, Yáñez-Mó M, de Ana AM, Martínez-A C, Mérida I, Sánchez-Madrid F.

J Immunol. 1999 Oct 1;163(7):4001-12.

11.

Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2.

Kershaw MH, Wang G, Westwood JA, Pachynski RK, Tiffany HL, Marincola FM, Wang E, Young HA, Murphy PM, Hwu P.

Hum Gene Ther. 2002 Nov 1;13(16):1971-80.

PMID:
12427307
12.

Heparin-disaccharide affects T cells: inhibition of NF-kappaB activation, cell migration, and modulation of intracellular signaling.

Hecht I, Hershkoviz R, Shivtiel S, Lapidot T, Cohen IR, Lider O, Cahalon L.

J Leukoc Biol. 2004 Jun;75(6):1139-46.

PMID:
15020655
13.

CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion.

Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, Zhang J, Ratajczak J, Ratajczak MZ.

J Mol Histol. 2004 Mar;35(3):233-45. Review.

PMID:
15339043
14.

Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapy.

Thanarajasingam U, Sanz L, Diaz R, Qiao J, Sanchez-Perez L, Kottke T, Thompson J, Chester J, Vile RG.

Cancer Res. 2007 Jan 1;67(1):300-8.

15.

Retention of CXCR4 in the endoplasmic reticulum blocks dissemination of a T cell hybridoma.

Zeelenberg IS, Ruuls-Van Stalle L, Roos E.

J Clin Invest. 2001 Jul;108(2):269-77.

16.

Synaptotagmin 3 deficiency in T cells impairs recycling of the chemokine receptor CXCR4 and thereby inhibits CXCL12 chemokine-induced migration.

Masztalerz A, Zeelenberg IS, Wijnands YM, de Bruijn R, Drager AM, Janssen H, Roos E.

J Cell Sci. 2007 Jan 15;120(Pt 2):219-28.

17.

Migration of antigen-specific T cells away from CXCR4-binding human immunodeficiency virus type 1 gp120.

Brainard DM, Tharp WG, Granado E, Miller N, Trocha AK, Ren XH, Conrad B, Terwilliger EF, Wyatt R, Walker BD, Poznansky MC.

J Virol. 2004 May;78(10):5184-93.

18.

Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokines.

Winter H, van den Engel NK, Rüttinger D, Schmidt J, Schiller M, Poehlein CH, Löhe F, Fox BA, Jauch KW, Hatz RA, Hu HM.

J Transl Med. 2007 Nov 14;5:56.

19.

The HIV-1 Gp120/CXCR4 axis promotes CCR7 ligand-dependent CD4 T cell migration: CCR7 homo- and CCR7/CXCR4 hetero-oligomer formation as a possible mechanism for up-regulation of functional CCR7.

Hayasaka H, Kobayashi D, Yoshimura H, Nakayama EE, Shioda T, Miyasaka M.

PLoS One. 2015 Feb 17;10(2):e0117454. doi: 10.1371/journal.pone.0117454.

Items per page

Supplemental Content

Support Center